Drug Shortage Report for INDERAL-LA
Report ID | 36376 |
Drug Identification Number | 02042258 |
Brand name | INDERAL-LA |
Common or Proper name | INDERAL LA |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PROPRANOLOL HYDROCHLORIDE |
Strength(s) | 80MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL |
Packaging size | 1x100 CAPS |
ATC code | C07AA |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-15 |
Estimated end date | |
Actual end date | 2018-02-07 |
Shortage status | Resolved |
Updated date | 2018-02-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-02-08 | French | Compare |
v4 | 2018-02-08 | English | Compare |
v3 | 2018-02-08 | English | Compare |
v2 | 2018-01-17 | French | Compare |
v1 | 2018-01-17 | English | Compare |
Showing 1 to 5 of 5